Sample annotations of the 556 high-risk neuroblastoma samples in the dataset, including clinical information and other information such as array platform and MYCN amplification status.
White blood cell count, platelet count, hemoglobin level, lactase dehydrogenase level, bone marrow blasts, de novo AML versus non de novo AML, performance status, sex, age, type A versus rare type NPM
